Harnessing m1A modification: a new frontier in cancer immunotherapy DOI Creative Commons
Xinru Wang, Xiaoqing Ma, Siyu Chen

et al.

Frontiers in Immunology, Journal Year: 2024, Volume and Issue: 15

Published: Dec. 2, 2024

N1-methyladenosine (m1A) modification is an epigenetic change that occurs on RNA molecules, regulated by a suite of enzymes including methyltransferases (writers), demethylases (erasers), and m1A-recognizing proteins (readers). This significantly impacts the function various biological processes affecting structure, stability, translation, metabolism, gene expression RNA. Thereby, m1A closely associated with occurrence progression cancer. review aims to explore role in tumor immunity. affects immune responses directly regulating cells indirectly modulating microenvironment. Besides, we also discuss implications m1A-mediated metabolic reprogramming its nexus checkpoint inhibitors, unveiling promising avenues for immunotherapeutic intervention. Additionally, m1AScore, established based patterns modification, can be used predict prognosis guide personalized therapy. Our underscores significance as burgeoning frontier cancer biology immuno-oncology, potential revolutionize treatment strategies.

Language: Английский

The epigenetic hallmarks of immune cells in cancer DOI Creative Commons
Ji Yu, Chu Xiao, Tao Fan

et al.

Molecular Cancer, Journal Year: 2025, Volume and Issue: 24(1)

Published: March 5, 2025

Targeting the dysregulation of epigenetic mechanisms in cancer has emerged as a promising therapeutic strategy. Although significant rationale progress therapies blocking cells, how regulation shapes tumor microenvironment (TME) and establishes antitumor immunity remains less understood. Recent study focus been put on epigenetic-mediated changes fate immune including differentiation, expansion, recruitment, functionalization, exhaustion T natural killer (NK) tumor-associated macrophages (TAMs), dendritic cells (DCs), myeloid-derived suppressor (MDSCs), B within TME. Here, we review latest molecular clinical insights into DNA modifications, histone modification, epitranscriptome-related regulations shape various cancers. We also discuss opportunities for leveraging to improve immunotherapies. This provides foundations proposes future direction combination therapies.

Language: Английский

Citations

2

FTO controls CD8+ T cell survival and effector response by modulating m6A methylation of Fas DOI Creative Commons
Lina Sun, Tianzhe Zhang, Ge Yao

et al.

Cell Death and Disease, Journal Year: 2025, Volume and Issue: 16(1)

Published: April 15, 2025

Abstract Functional CD8 + T cell immunity is essential for immune surveillance and host defense against infection tumors. Epigenetic mechanisms, particularly RNA modification, in controlling response not fully elucidated. Here, by cell-specific deletion of fat mass obesity-associated protein (FTO), a critical N6-methyladenosine (m 6 A) demethylase, we revealed that FTO was indispensable adequate protective function. ablation led to considerable death activated cells, which attributed apoptosis. MeRIP-seq analysis an increase m A methylation on Fas mRNA FTO-deficient cells. The loss promoted expression via enhancing the stability, depended reader insulin-like growth factor-2 mRNA-biding proteins 3 (IGF2BP3). Mutation sites or knockdown IGF2BP3 could normalize upregulated apoptosis levels caused Our findings delineate novel epigenetic regulatory mechanism FTO-mediated modification supporting survival effector responses, providing new insights into understanding post-transcriptional regulation immunological functions potential therapeutic intervention.

Language: Английский

Citations

1

Specific deletion of Mettl3 in IECs triggers the development of spontaneous colitis and dysbiosis of T lymphocytes in mice DOI
Miao Fang, Jie Yao, Haifeng Zhang

et al.

Clinical & Experimental Immunology, Journal Year: 2024, Volume and Issue: 217(1), P. 57 - 77

Published: March 20, 2024

Abstract The enzymatic core component of m6A writer complex, Mettl3, plays a crucial role in facilitating the development and progress gastric colorectal cancer (CRC). However, its underlying mechanism regulating intestinal inflammation remains unclear poorly investigated. First, characteristics Mettl3 expression inflammatory bowel diseases (IBD) patients were examined. Afterward, we generated mice line with epithelial cells (IECs)-specific deletion verified by various experiments. We continuously recorded compared physiological status including survival rate etc. between two groups. Subsequently, took advantage staining assays to analyze mucosal damage immune infiltration Mettl3WT Mettl3KO primary IECs. Bulk RNA sequencing was used pursuit differential genes (DEGs) associated signaling pathways after losing Mettl3. Pyroptosis-related proteins determine whether cell death caused pyroptosis. Eventually, CyTOF performed probe difference CD45+ cells, especially CD3e+ T-cell clusters In IBD patients, highly expressed inner-nucleus IECs while significantly decreased upon acute inflammation. IECs-specific KO triggered wasting phenotype developed spontaneous colitis. rate, body weight, length observed from 2 8 weeks lower than mice. degree even more serious their WT littermate. demonstrated that DEGs dramatically enriched NOD-signaling due loss colonic epithelium prone pyroptosis revealed T have altered Mettl3KO. Furthermore, there abnormal proliferation CD4+ markedly exhaustion CD8 + severe is located declined when occurs. prevented developing

Language: Английский

Citations

4

T cell-based cancer immunotherapy: opportunities and challenges DOI
Kaili Ma, Yingxi Xu,

Hongcheng Cheng

et al.

Science Bulletin, Journal Year: 2025, Volume and Issue: unknown

Published: March 1, 2025

Language: Английский

Citations

0

Role and regulators of N6-methyladenosine (m6A) RNA methylation in inflammatory subtypes of asthma: a comprehensive review DOI Creative Commons
Ge Gao,

Yu Qiu Hao,

Chen Wang

et al.

Frontiers in Pharmacology, Journal Year: 2024, Volume and Issue: 15

Published: July 23, 2024

Asthma is a common chronic inflammatory disease of the lungs and airway, yet its subtypes potential pathogenesis have not been completely elucidated require further study. With advances in epigenetic development, methylation has emerged as new direction for identifying decoding occurrence subtype manifestations asthma. N 6 -methyladenosine (m A), an RNA modification occurring -position adenosine, prevalent observed eukaryotes. It exerts significant control over mRNA metabolism by regulating alternative splicing, stability, export, translation. The dynamic process m A plays crucial role asthma tightly regulated three types regulators: writers, readers, erasers. This article provides comprehensive review association between regulators asthma, such involvement cells related response. Furthermore, findings presented herein provide insights solid foundation research on biomarkers diagnosis development personalized treatment different particularly neutrophilic eosinophilic

Language: Английский

Citations

3

The indispensability of methyltransferase-like 3 in the immune system: from maintaining homeostasis to driving function DOI Creative Commons

Mingfu Zhang,

Zhixian Gou,

Yi Qu

et al.

Frontiers in Immunology, Journal Year: 2024, Volume and Issue: 15

Published: Oct. 2, 2024

Methyltransferase-like 3(METTL3), recognized as the primary N

Language: Английский

Citations

3

METTL3 governs thymocyte development and thymic involution by regulating ferroptosis DOI

Huiru Jing,

Jiayu Song, Jie Sun

et al.

Nature Aging, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 23, 2024

Language: Английский

Citations

3

The Role of M6A Modification in Autoimmunity: Emerging Mechanisms and Therapeutic Implications DOI
Liyun Xu, Tian Shen, Yongzhen Li

et al.

Clinical Reviews in Allergy & Immunology, Journal Year: 2025, Volume and Issue: 68(1)

Published: March 14, 2025

Language: Английский

Citations

0

An automatic annotation tool and reference database for T cell subtypes and states at single-cell resolution DOI Creative Commons

Wen‐Kang Shen,

Chuyu Zhang, Y. T. Gu

et al.

Science Bulletin, Journal Year: 2025, Volume and Issue: unknown

Published: March 1, 2025

Language: Английский

Citations

0

The microbiota-m6A-metabolism axis: Implications for therapeutic strategies in gastrointestinal cancers DOI
Xiuxiu Qiu,

Qi Gao,

Jiahui Wang

et al.

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Journal Year: 2025, Volume and Issue: 1880(3), P. 189317 - 189317

Published: April 11, 2025

Language: Английский

Citations

0